(Q44916343)

7 December 2017

title

Association of anemia with outcomes in men with moderate and severe chronic kidney disease (English)

1 reference

7 December 2017

author

Kamyar Kalantar-Zadeh

series ordinal

3

1 reference

7 December 2017

Kovesdy CP

1

1 reference

7 December 2017

Trivedi BK

series ordinal

2

1 reference

7 December 2017

Anderson JE

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

7 December 2017

1 reference

7 December 2017

volume

69

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

560-564

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000105

7 December 2017

exact match

0 references

cites work

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Use of erythropoietin before the initiation of dialysis and its impact on mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Cardiovascular effects of recombinant human erythropoietin in predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Anemia management and the delay of chronic renal failure progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000105

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000105

1 reference

Dimensions Publication ID

7 December 2017

1025454303

0 references

1 reference